Evidence map›Paper›PMID 33033064›Full record

ArticleDiabetes2021

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.

Aurora Merovci, Devjit Tripathy, Xi Chen, Ivan Valdez, Muhammad Abdul-Ghani, Carolina Solis-Herrera, Amalia Gastaldelli, Ralph A DeFronzo

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Insulin Clearance in Obesity and Type 2 Diabetes.International journal of molecular sciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Aurora MerovciDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.
Devjit TripathyDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.
Xi ChenDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.
Ivan ValdezDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.
Muhammad Abdul-GhaniDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.ORCID 0000-0003-4556-1787
Carolina Solis-HerreraDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.ORCID 0000-0002-6215-9418
Amalia GastaldelliDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX.ORCID 0000-0003-2594-1651
Ralph A DeFronzoDivision of Diabetes, Department of Medicine, University of Texas Health Science Center, San Antonio, TX albarado@uthscsa.edu.ORCID 0000-0002-8581-6273
The University of Texas Health Science Center at San Antonio · US

Funding

SGLT2 Inhibitors, Ketogenesis, and KetoacidosisR01DK024092 · NIDDK · YALE UNIVERSITY · PI RALPH A DEFRONZO · 1986 to 2026
$12.7M
Regulation of Hepatic and Peripheral Glucose MetabolismR56DK024092 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI DEFRONZO, RALPH A · 2005 to 2005
$73k
NIDDK NIH HHS R01 DK024092NIDDK NIH HHS R56 DK024092
6 · The paper itself

Abstract

The aim of the current study was to evaluate the effect of sustained physiologic increase of ∼50 mg/dL in plasma glucose concentration on insulin secretion in normal glucose-tolerant (NGT) subjects. Twelve NGT subjects without family history of type 2 diabetes mellitus (T2DM; FH-) and 8 NGT with family history of T2DM (FH+) received an oral glucose tolerance test and two-step hyperglycemic clamp (100 and 300 mg/dL) followed by intravenous arginine bolus before and after 72-h glucose infusion. Fasting plasma glucose increased from 94 ± 2 to 142 ± 4 mg/dL for 72 h. First-phase insulin secretion (0-10 min) increased by 70%, while second-phase insulin secretion during the first (10-80 min) and second (90-160 min) hyperglycemic clamp steps increased by 3.8-fold and 1.9-fold, respectively, following 72 h of physiologic hyperglycemia. Insulin sensitivity during hyperglycemic clamp declined by ∼30% and ∼55% (both

Indexed as

AdultBlood GlucoseFemaleGlucose Clamp TechniqueGlucose Tolerance TestHealthy VolunteersHumansHyperglycemiaInsulinInsulin ResistanceInsulin SecretionMaleMiddle AgedBlood GlucoseInsulin

Identifiers

PMID33033064
PMCPMC7881846
OpenAlexW3092502456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.